Sarda Proteins board approves rights issue up to Rs 100 crore

Sarda Proteins board approved a rights issue of fully paid-up equity shares (face value Rs 10) for an amount not exceeding Rs 100 crore. Eligible shareholders as on the record date, to be notified later, can participate. Draft Letter of Offer was approved and a Rights Issue Committee was formed. Separately, non-executive director Mr. Gunvantray Zaladi resigned due to personal reasons effective August 5, 2026.